Amdocs (NASDAQ:DOX) Share Price Passes Above 200 Day Moving Average - Should You Sell?

Key Points

• Amdocs shares moved above their 200-day moving average, reaching $62.05 before last trading at $61.40. The stock’s 200-day average is $61.64, while its 50-day average is $54.25.
• Analyst sentiment is mixed but leans cautious: three analysts rate Amdocs Buy, three rate it Hold, and one rates it Sell. The consensus rating is Hold, with a target price of $86.67.
• Amdocs announced a quarterly dividend of $0.569 per share, equivalent to $2.28 annually and a 3.7% yield. Institutional investors own 92.02% of the company’s shares.

Amdocs Limited (NASDAQ:DOX - Get Free Report)'s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $61.64 and traded as high as $62.05. Amdocs shares last traded at $61.40, with a volume of 1,316,848 shares changing hands.

Analyst Ratings Changes

A number of analysts have commented on the stock. KeyCorp started coverage on shares of Amdocs in a research note on Monday, June 29th. They set a "sector weight" rating for the company. Wall Street Zen downgraded Amdocs from a "buy" rating to a "hold" rating in a research note on Sunday, July 5th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Amdocs in a report on Wednesday, August 5th. Stifel Nicolaus reduced their target price on shares of Amdocs from $88.00 to $71.00 and set a "buy" rating for the company in a research note on Thursday, May 14th. Finally, Cfra downgraded shares of Amdocs to a "sell" rating in a research report on Thursday, May 14th. Three analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $86.67.

Amdocs Stock Performance

The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.98 and a current ratio of 0.94. The company has a market cap of $6.63 billion, a PE ratio of 14.62, a price-to-earnings-growth ratio of 1.06 and a beta of 0.40. The company's 50 day moving average price is $54.25 and its 200-day moving average price is $61.64.

Amdocs Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.569 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $2.28 annualized dividend and a dividend yield of 3.7%. Amdocs's payout ratio is presently 54.05%.

Institutional Investors Weigh In On Amdocs

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. WealthCollab LLC boosted its position in Amdocs by 94.5% during the third quarter. WealthCollab LLC now owns 356 shares of the technology company's stock worth $29,000 after purchasing an additional 173 shares during the period. BOK Financial Private Wealth Inc. bought a new stake in shares of Amdocs in the fourth quarter valued at approximately $37,000. Los Angeles Capital Management LLC purchased a new stake in shares of Amdocs during the 4th quarter valued at approximately $39,000. Advisory Services Network LLC purchased a new stake in shares of Amdocs during the 3rd quarter valued at approximately $42,000. Finally, CIBC Private Wealth Group LLC boosted its holdings in Amdocs by 190.2% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 595 shares of the technology company's stock worth $49,000 after buying an additional 390 shares during the period. 92.02% of the stock is currently owned by institutional investors.

About Amdocs

Amdocs NASDAQ: DOX is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source